People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroPace Inc | — | Other Health Care | Series C | $208.6M | $1.5B | 2011 |
| Autonomic Technologies Inc | — | Other Health Care | Series C | $125.6M | $1.1B | 2009 |
| Align Technology Inc | — | Biotechnology | Series C | $72.3M | $3.0B | 2009 |
| Ophthonix Inc | — | Other Health Care | Series A | $24.7M | $283.4M | 2010 |
Joseph Lacob at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph Lacob on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Fischer | 2 | 5 |
| Rishi Gupta | 1 | 12 |
| Nael Kassar | 1 | 11 |
| Jonathan Silverstein | 1 | 10 |
| James Blair | 1 | 8 |
| Greg Garfield | 1 | 8 |
| Reza Zadno | 1 | 7 |
| Dana Mead | 1 | 7 |
| Michael Sweeney | 1 | 7 |
| David Fischell | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Gilbert H. Kliman | 1 | 5 |
| Kevin Wasserstein | 1 | 5 |
| Benjamin Pless | 1 | 5 |
| Thomas M. Prescott | 1 | 4 |
| Brad Vale | 1 | 4 |
| Evan Norton | 1 | 4 |
| Steven D. Weinstein | 1 | 3 |
| Vince Burgess | 1 | 3 |
| Ray Larkin | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.